Quick Answer
Folate Cognition Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Background : The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study was a 3-year randomized controlled trial to test the effects of the MIND diet on cognitive decline in individuals at risk for Alzheimer's dementia (AD).
Key Takeaways
- 01Background : The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study was a 3-year randomized controlled trial to test the effects of the MIND diet on cognitive decline in individuals at risk for Alzheimer's dementia (AD). [Cornelis MC (2026)]
- 02Met / Met (lower enzyme activity) carriers' perceptual speed improved more on the MIND than the control diet, while no difference by diet was observed for Val carriers. [Cornelis MC (2026)]
- 03Here we examine whether genetic differences in (a) AD predisposition and (b) nutrient metabolism modify the effect of MIND on cognitive change. [Cornelis MC (2026)]
- 04This mini-review synthesizes current evidence on dietary and lifestyle interventions for AD prevention and management from randomized controlled trials (RCTs) and observational studies. [Zhang H (2026)]
The current Migaku evidence database contains 2 reusable source documents for Folate Cognition Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- Background : The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study was a 3-year randomized controlled trial to test the effects of the MIND diet on cognitive decline in individuals at risk for Alzheimer's dementia (AD). [Cornelis MC (2026); evidence level 2]
- Met / Met (lower enzyme activity) carriers' perceptual speed improved more on the MIND than the control diet, while no difference by diet was observed for Val carriers. [Cornelis MC (2026); evidence level 2]
- Here we examine whether genetic differences in (a) AD predisposition and (b) nutrient metabolism modify the effect of MIND on cognitive change. [Cornelis MC (2026); evidence level 2]
- This mini-review synthesizes current evidence on dietary and lifestyle interventions for AD prevention and management from randomized controlled trials (RCTs) and observational studies. [Zhang H (2026); evidence level 3]
- Current findings indicate that multidomain approaches, such as the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and the Finnish Geriatric Intervention Study (FINGER) model, which integrate nutrition, physical activity, and cognitive training, consistently demonstrate efficacy in slowing cognitive decline and reducing brain atrophy in at-risk elderly populations. [Zhang H (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources